Granted Patent B2

US 12,515,030 · App. 18/662,905 · Granted Jan 6, 2026

Inventors: Andrew L. Johnston (Redwood City, CA); Michael P. Schaller (Louisville, CO); Bryce Peterson (Redwood City, CA); Kevin Gelston (Moraga, CA)

Assignee: Morningside Venture Investments Limited

A61M35/00A61K9/703A61M5/14248A61M5/145A61M5/1454A61M2005/14268A61M2005/14533A61M2205/103A61M2205/106A61M2205/502A61M2205/8206

Abstract

Claims (29)

1 . A transdermal drug delivery device comprising:

a reservoir configured to hold a formulation therein;

a transdermal membrane configured to allow the formulation from the reservoir to pass therethrough;

a piston configured to move into the reservoir;

a control rod attached to the piston, the control rod including a plurality of teeth thereon;

a spring configured to apply rotational force to the control rod in the direction of the reservoir; and

a rotational cam having a first camming surface and a second camming surface, the first camming surface and the second camming surface configured to engage with the plurality of teeth,

wherein the rotational cam, when rotated, is configured to disengage the first camming surface from a first tooth of the plurality of teeth, thereby allowing the spring to advance the piston into the reservoir to expel the formulation onto the transdermal membrane, and

wherein the rotational cam is rotatable in a first direction to cause the first camming surface to disengage with the first tooth of the plurality of teeth and the second camming surface to engage with a second tooth of the plurality of teeth, and wherein the rotatable cam is rotatable in a second direction to cause the second camming surface to disengage from the first tooth of the plurality of teeth and cause the piston to move further into the reservoir to expel more of the formulation.

2 . The transdermal drug delivery device of claim 1 , wherein the device is configured such that, after the first camming surface disengages from the first tooth of the plurality of teeth and pushes the spring to push the control rod and piston into the reservoir, the second camming surface is configured to engage with the second tooth of the plurality of teeth to stop the piston from moving further into the reservoir.

3 . The transdermal drug delivery device of claim 1 , wherein the rotational cam is rotatable alternately in the first and second directions to allow sequential bolus deliveries of the formulation.

4 . The transdermal drug delivery device of claim 1 , wherein the rotational cam is rotatable in a same direction so as to deliver sequential doses of the formulation.

5 . The transdermal drug delivery device of claim 1 , wherein the rotational cam is rotatable a first distance in a first direction to cause the first camming surface to disengage with the first tooth of the plurality of teeth and the second camming surface to engage with the second tooth of the plurality of teeth, and wherein the rotatable cam is rotatable a second distance in the first direction to cause the second camming surface to disengage from the second tooth of the plurality of teeth and cause the piston to move further into the reservoir to expel more of the formulation.

6 . The transdermal drug delivery device of claim 1 , further comprising a check valve disposed along a pathway between the reservoir and the transdermal membrane.

7 . The transdermal drug delivery device of claim 1 , further comprising a control unit configured to rotate the rotatable cam.

8 . The transdermal drug delivery device of claim 1 , further comprising a disposable part and a reusable part.

9 . The transdermal drug delivery device of claim 1 , wherein a first part further includes a storage latch configured to hold the spring away from the control rod during storage, the storage latch configured to release the spring when the first part and a second part are engaged.

10 . The transdermal drug delivery device of claim 1 , wherein the control rod is configured to deliver non-uniform bolus volumes.

11 . The transdermal drug delivery device of claim 1 , wherein a spacing between the plurality of teeth on the control rod defines a teeth spacing pattern corresponding to a drug delivery profile of the transdermal drug delivery device.

12 . The transdermal drug delivery device of claim 1 , wherein a drug delivery profile corresponds to a circadian rhythm or a bio-synchronous pattern of a patient using the transdermal drug delivery device.

13 . The transdermal drug delivery device of claim 1 , wherein the plurality of teeth are configured to deliver two or more bolus volumes.

14 . The transdermal drug delivery device of claim 1 , wherein the formulation is selected from the group consisting of: nicotine, Acamprosate, Acetaminophen, Alfentanil, Allopurinol, Almotriptan, Alprazolam, Amitriptylinem, Amoxapine, Apomorphine, Aripiprazole, Armodafinil, Asenapine, Atomoxetine, Azelastine, Baclofen, Benzbromarone, Benzydamine, Brexpiprazole, Budesonide, Bupivacaine, Buprenorphine, Buprenorphine, Bupropion, Buspirone, Cabergoline, Capsaicin, Carbamazepine, Carbidopa, Carisprodol, Celecoxib, Citalopram, Clobazam, Clonazepam, Clonidine, Clopidogrel, Colchicine, Cyclobenzaprine, Dalteparin, Desvenlafaxine, Dexamfetamine, Dexmethylphenidate, Diazepam, Diclofenac, Disulfiram, Divalproex, Dolasetron, Doxepin, Dronabinol, Droxidopa, Duloxetine, Eletriptan, Entacapone, Escitalopram, Eslicarbazepine, Esomeprazole, Estradiol, Estrogen, Eszopiclone, Ethosuximide, Etodolac, Ezogabine, Febuxostat, Felbamate, Fenbufen, Fentanyl, Flunisolide, Fluorouracil, Fluoxetine, Fluticasone, Fluvoxamine, Formoterol, Fosphenytoin, Frovatriptan, Gabapentin, Granisetron, Guanfacine, Hydrocodone, Hydrocodone, Hydrocortisone, Hydromorphone, Hydroxyzine, Hypericum Extract, Ibuprofen, Indometacin, Ketorolac, Lacosamide, Lamotrigine, Levetiracetam, Levodopa, Levomilnacipran, Levosalbutamol, Lidocaine, Lisdexamfetamine, Lithium, Lorazepam, Lorcaserin, Losartan, Loxapine, Meclizine, Meloxicam, Metaxalone, Methylphenidate, Milnacipran, Mirtazapine, Modafinil, Morphine, Nabilone, Nadolol, Naloxone, Naltrexone, Naproxen, Naratriptan, Nedocromil, Nefazodone, Nitroglycerin, Olanzapine, Ondansetron, Orlistat, Oxaprozin, Oxcarbazepine, Oxybutynin, Oxycodone, Oxymorphone, Palonosetro, Pamidronate, Paroxetine, Perampanel, Phentermine, Phentolamine, Pramipexole, Prasugrel, Prazepam, Prednisone, Pregabalin, Procaine, Promethazine, Propofol, Quetiapine, Ramelteon, Rasagiline, Remifentanil, Risperidone, Rivastigmine, Rizatriptan, Ropinirole, Ropivacaine, Rotigotine, Rufinamide, Salbutamol, Scopolamine, Selegiline, Sertraline, Sodium Oxybate, Strontium, Sufentanil, Sumatriptan, Suvorexant, Tapentadol, Tasimelteon, Temazepam, Testosterone, Tetracaine, Theophylline, Tiagabine, Tiotropium, Tirofiban, Tolcapone, Topiramate, Tramadol, Trazodone, Triazolam, Trimipramine, Valproic acid, Venlafaxine, Vigabatrin, Vilazodone, Vortioxetine, Zaleplon, Zileuton, Ziprasidone, Zolmitriptan, Zolpidem, Norethisterone, Enalapril, Ethinyl Estradiol, Insulin, Memantine, Methamphetamine, Norelgestromine, Pergolide, Ramipril, Tecrine, Timolol, Tolterodine, and Zonisamide.

15 . A method of transdermal drug delivery, the method comprising:

applying a transdermal delivery system to the skin of a patient, the transdermal delivery system including a reservoir, a transdermal membrane, a piston, a control rod having a plurality of teeth, a spring configured to engage the control rod, and a rotational cam having first and second camming surfaces configured to engage the plurality of teeth on the control rod;

rotating the rotational cam to disengage the first camming surface from a first tooth of the plurality of teeth, thereby allowing the spring to advance the piston into the reservoir to expel a formulation onto the transdermal membrane;

rotating the rotational cam in a first direction to cause the first camming surface to disengage with the first tooth of the plurality of teeth and the second camming surface to engage with a second tooth of the plurality of teeth; and

rotating the rotatable cam in a second direction to cause the second camming surface to disengage from the first tooth of the plurality of teeth and cause the piston to move further into the reservoir to expel more of the formulation.

16 . The method of claim 15 , further comprising engaging, with the second camming surface, the second tooth of the plurality of teeth to stop the piston from moving further into the reservoir.

17 . The method of claim 15 , wherein rotating the rotational cam comprises moving the first camming surface from a first position that engages with a first tooth of the plurality of teeth to a second position that disengages with the first tooth such that the piston advances and pushes a dose of a formulation out of the reservoir, onto the transdermal membrane, and to the skin of the patient.

Assignments (3)

Continuity (4)

References Cited (400)